* Guardion Health Sciences Inc GHSI.OQ GHSI.O is
expected
to show a fall in quarterly revenue when it reports results on
May 13 (estimated) for the period ending March 31 2024
* The Houston Texas-based company is expected to report a
2.0% decrease in revenue to $3.122 million from $3.19 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Guardion Health Sciences
Inc
is for a loss of 88 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Guardion
Health
Sciences Inc is $40.00, above its last closing price of $8.09.
This summary was machine generated May 10 at 13:35 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)